Published: March 2023 | Report Code: 12567 | Available Format: PDF
The global liquid handling system market was valued at USD 4,692 million in 2022, which is expected to reach USD 6,521 million by 2030, progressing with a CAGR of 4.20% during 2022–2030. The growth is attributed to the booming life sciences industry, increasing prevalence of chronic diseases, and rising investment by companies for developing innovative and effective therapeutic agents.
Moreover, due to the pandemic, the demand for these products drastically increased throughout the world. These systems were utilized during all types of laboratory work that was carried out during the testing of COVID-19 samples. Additionally, the spur in the count of clinical trials of vaccines and other kinds of promising treatments increased the demand for such systems.
Emerging economies, such as China and India, are offering lucrative opportunities to drug manufacturers and other life sciences companies. For instance, in May 2022, Pfizer Inc. opened an R&D center at IIT Madras Research Park, Chennai, India, to advance pharmaceutical research in the country.
The demand for automated systems is forecast to increase faster in the coming years. Such variants reduce the need for manpower and provide accurate dispensing. Moreover, the increasing R&D investment by drug manufacturers and life science companies and the strong government support for the establishment of advanced research centers are playing a pivotal role in the growth of the category.
Moreover, the launch of new automated liquid handling equipment is driving the market during the forecast period. For instance:
The manual category also holds a significant share in the market, and it will grow with a robust CAGR during the forecast period. In developing countries, such as India, China, and Brazil, the smaller laboratories still prefer manual systems over automated or digital ones, due to the former’s low cost and ease of use.
In 2022, pipettes held the largest share, of more than 21%, in the liquid handling system market, and this trend will be maintained throughout the forecast period. It is due to the increase in the number of pipette calibration service providers and the introduction of advanced pipettes. For instance, in May 2022, Eppendorf Corporate opened the Sophisticated Pipette Laboratory and Service Hub (SPLASH) in Chennai.
The dispenser category also holds a significant share, due to the introduction of advanced dispensing systems. Sartorius’s rLINE robotic liquid handling dispenser is one such advanced product. It provides accurate and reliable sample processing with its electronic braking system, DC motor, optical sensor, conductive robotic tips, and liquid level sensor.
Liquid handling systems are the most frequently used for making drug discoveries, which is why this category held a major share in 2022. More than 20,000 drugs under development are expected to be launched in the coming years. Liquid handling systems hold high importance in each stage of the drug discovery process. Moreover, companies are focusing on capacity expansions for discovering drugs.
The clinical diagnostics category holds the second-largest share, primarily due to the increasing prevalence of chronic diseases. Liquid handling systems are widely used at diagnostic centers and even the diagnostic laboratories at hospitals.
Liquid handling systems have a wide variety of applications in the life sciences industry. They are used in research activities for drug discovery & development, toxicity screening, biopharmaceutical production, drug screening, tissue engineering, and forensic testing, to name a few. The active participation of government organizations in making the life sciences sector more organized is a key driving factor for this industry. The grants offered are used for research on health, climate change, synthetic biology, and sustainable bioresource management.
Moreover, the remarkable growth in genomic profiling and analysis has given access to numerous avenues in the pharmaceutical and diagnostic sectors, especially in the area of precision medicine. Similarly, the widespread use of NGS in diagnostic laboratories has enhanced the accuracy of genetic testing with high consistency. Genomic study in healthcare research is one of the key applications of the NGS, where advanced techniques are being used for predictive genetic testing and prenatal diagnosis.
The increasing number of mergers and acquisitions is one of the major trends being observed in the market. The objective of this strategic development is an increase in the share for companies, their geographical expansion, enrichment of their product portfolios, and the achievement of a larger customer base.
Some of the recent mergers & acquisitions are:
Report Attribute | Details |
Historical Years |
2017-2022 |
Forecast Years |
2023-2030 |
Market Size in 2022 |
USD 4,692 Million |
Revenue Forecast in 2030 |
USD 6,521 Million |
Growth Rate |
4.20% CAGR |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Segments Covered |
By Type; By Product; By Application; By End User; By Region |
Explore more about this report - Request free sample pages
North America held the largest share, of around 36%, in 2022 due to the increasing number of mergers & acquisitions among biotechnology companies. Moreover, the growing pharmaceutical and biotechnology industries are having a positive impact on the market growth. Moreover, companies are investing in the consumer healthcare business to develop effective therapies.
The U.S. market is predicted to generate a significant revenue by 2030, growing at a CAGR of around 4.5% during the forecast period. This can be mainly attributed to the presence of a large number of major healthcare device and pharmaceutical companies and the increase in the need for the proper management and stabilization of pharmaceutical and biotechnical production processes.
Moreover, European market generated a significant growth in 2022. This regional market is significantly supported by the rising awareness of the DNA’s medical significance, ample financial capacity to purchase pricey tools, and favorable reimbursement policies. Numerous cutting-edge applications in studies, including genotyping, expression analysis, and molecular diagnostic testing, may present opportunities for the market players in the region.
Additionally, government bodies are increasingly investing in the development of advanced labs, in partnership with numerous research institutes and organizations, because they provide important genetic insights into the nature of diseases. The growing demand for liquid handling solutions and increasing government funding for R&D in Europe are the main factors driving this market. The rising use of personalized medicine and diagnostics and the latest genetics-enhancing technology and the lessons learned from genetic sequencing are also driving the region's market growth.
Moreover, the APAC region is projected to witness the fastest growth, at a CAGR of over around 5.1%, during the forecast period, attributed to the rise in the investments in the field of biotechnology. In APAC, the Chinese market held the largest revenue share in 2022, and it is projected to progress at a significant CAGR during the forecast period. This is mainly due to a large number of R&D activities underway in the life sciences industry in the country.
Japan has contributed significantly to the APAC market as well. The country is witnessing collaborations among various industry participants and stakeholders, such as the International Nucleotide Sequence Database Collaboration (INSDC) between the European Bioinformatics Institute (EMBL-EBI), the National Centre of Biotechnology Information (NCBI) in the U.S., and the DNA Data Bank of Japan (DDBJ). The DDBJ provides share data from life science research and analyzes it.
India will witness considerable market growth in this region as it is investing massively in the advancement of its healthcare and medical research ecosystems. The country is home to a highly heterogeneous population and genetic diversity, which also contribute to the high prevalence of recessive alleles, often translating into genetic diseases, including rare diseases. Thus, to reduce the burden of these diseases and accelerate their diagnosis and management, the government is planning to speed up research in the field with various projects.
LATAM is comparatively a small market for liquid handling systems, and it is set to witness moderate growth during the forecast period. The growing biotechnology industry and, consequently, the increasing use of analytical technologies and the rising R&D expenditure by the pharmaceutical companies in the region have been driving the growth of the LATAM market.
The MEA market holds the smallest share in the global market, and it will witness significant growth during the forecast period. The increasing requirement for customized medicines, technological advancements, and increasing financing for proteomics ventures are driving the MEA market.
The study uncovers the biggest trends and opportunities in the liquid handling system market, along with offering segmentation analysis at the granular level for the period 2017 to 2030.
Based on Type
Based on Product
Based on Application
Based on End Users
Geographical Analysis
The 2022 size of the market for liquid handling systems was USD 4,692 million.
Pipettes dominate the liquid handling system industry, based on product.
The market for liquid handling systems is driven by the expanding life sciences industry, itself due to the rising prevalence of all kinds of diseases.
North America holds the largest share in the liquid handling system industry and Europe the second-largest share; APAC will have the highest CAGR.
Drug discovery is the biggest application in the market for liquid handling systems.
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws